Following the merger of Solexa and Lynx Therapeutics, Solexa CEO John West will become chief executive officer of the combined company, the companies said yesterday. West joined Solexa last month from Applied Biosystems, where he was vice president of DNA platforms. He will also join the board of directors of the merged company, which will also include Craig Taylor, chairman of Lynx Therapeutics, and four venture capital members of the current Solexa board.
Arthur Mandell has become president and CEO of Cellective Therapeutics, the Durham, N.C.-based antibody therapeutics company said today. In the past, he was a senior vice president and chief business officer at Human Genome Sciences.
Harry Wilcox is the new senior vice president and CFO of Exact Sciences, the Marlborough, Mass.-based company said yesterday. He joins the company from Beacon BioPartners, where he was a partner. Prior to that, he was interim CEO of Biostratum and executive vice president and chief of finance and corporate development at Pyrosequencing.
Peter Miller has become vice president of marketing and sales for CeMines' bioystems division, the Golden, Colo.-based company said last week. He was previously general manager and director of sales and marketing for Proligo. He holds an MBA in pharmaceutical marketing from Fairleigh Dickinson University and a bachelor's degree in biology and business administration from Winona State University of
Prometic Life Sciences of
Jane Green has become vice president for corporate communications of Dynavax Technologies, the Berkeley, Calif.-based company said on Monday. She joins the company from Exelixis, where she developed and managed the company's communications strategy. Prior to that, she was senior director of corporate communications at Caliper Technologies. Green holds a PhD in English literature from the State University of New York at Buffalo and a BA in literature from the
Takashi Nakamura has been appointed to the business advisory board of GeneEd, the San Francisco-based company said last week. In the past, he held a position at GeneFormatics. Nakamura received a BS in computer science and mathematics from the
GenoMed of St. Louis said yesterday it has added new members to its scientific advisory board, who will serve on a sub-committee dealing with ethical, legal, and social issues: Sylvia Johnson, director of research and epidemiology for the United Automobile Aerospace and Agricultural Implement Works of America; David Sundwall, chairman of the CDC's Clinical Laboratory Improvement Act Advisory Committee; Sheryl Dasco, a health attorney in Texas; David Moskowitz, CEO and chief medical officer of GenoMed; and Dennis Robbins, an ethics advisor who will chair the committee.
Matthew Meselson has won the Albert Lasker Award for Special Achievement in Medical Science, the Lasker Foundation said on Sunday. He is a professor of natural sciences at
Joseph DeRisi and Vamsi Mootha are among the 23 new MacArthur fellows named by the MacArthur Foundation yesterday. Each fellow will receive $500,000 over the next five years. DeRisi, who has been developing microarrays, is an assistant professor of biochemistry and biophysics at the
David Pall, the founder of Pall Corporation, died last week, according to an article in the New York Times. He was 90. Pall invented sophisticated filters, for example for purifying blood for transfusions. In 1946, he started the Micro Metallic Corporation, which is now the Pall Corporation, based in